Showing results (51-60 of 109) with videos related to
Sort By:
Pageof 11
Blood|May 1, 1991
Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effectJ B Bussel, J N Graziano, R P Kimberly, et al.The Journal of Laboratory and Clinical Medicine|March 1, 1986
Calcium-specific immunoassays for factor IX: reduced levels of antigen in patients with vitamin K disordersG L Bray, A F Weinmann, A R ThompsonAmerican Journal of Medical Genetics|May 1, 1986
Concurrence of von Willebrand's disease and hemophilia A: implications for carrier detection and prevalenceC H Miller, M W Hilgartner, M B Harris, et al.Journal of Acquired Immune Deficiency Syndromes|March 1, 1994
HIV-1 infection incidence among persons with hemophilia in the United States and western Europe, 1978-1990. Multicenter Hemophilia Cohort StudyB L Kroner, P S Rosenberg, L M Aledort, et al.Thrombosis and Haemostasis|June 3, 1998
Prophylactic use of factor VIII: an economic evaluationR L Bohn, J Avorn, R J Glynn, et al.The American Journal of Pediatric Hematology/Oncology|February 1, 1994
Assessing clinical severity in children with sickle cell disease. Preliminary results from a cooperative studyG L Bray, L Muenz, N Makris, et al.International Journal of Technology Assessment in Health Care|January 1, 1995
Hemophilia home treatment. Economic analysis and implications for health policyD Ross-Degnan, S B Soumerai, J Avorn, et al.La Ricerca in Clinica E in Laboratorio|January 1, 1983
Impact of factor VIII deficiency on clotting factor utilization in the United StatesL M Aledort, S H Goodnight, A V Rao, et al.Annals of Internal Medicine|November 15, 1991
Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV)M E Eyster, H J Alter, L M Aledort, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 14, 2004
The economic impact of factor VIII inhibitors in patients with haemophiliaR L Bohn, L M Aledort, K G Putnam, et al.Pageof 11